Skip to main content

Table 2 Univariate analysis of tumor markers

From: CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy

Tumor marker Hazard ratio (95% CI) P value
pre-AFU > 45.1 1.607 (0.504, 5.126) 0.423
pre-AFP > 2.6 1.294 (0.810, 2.066) 0.280
pre-CEA > 1.6 1.193 (0.841, 1.893) 0.322
pre-CA199 > 24.9 1.729 (1.187, 2.519) 0.004
pre-CA125 > 16 2.337 (1.515, 3.606) 0.000
pre-CA724 > 4.6 2.033 (1.391, 2.972) 0.000
post-AFU > 40.9 0.995 (0.517, 1.915) 0.988
post-AFP > 4.6 1.697 (0.958, 3.005) 0.070
post-CEA > 3.3 1.220 (0.813, 1.831) 0.337
post-CA199 > 62.6 2.447 (1.515, 3.954) 0.000
post-CA125 > 11.2 2.187 (1.352, 3.536) 0.001
post-CA724 > 5.9 2.246 (1.460, 3.455) 0.000
diff-AFU > 0 0.742 (0.290, 1.899) 0.533
diff-AFP > 0 1.017 (0.718, 1.439) 0.924
diff-CEA > 0 0.992 (0.814, 1.120) 0.940
diff-CA199 > 0 1.217 (1.000, 1.481) 0.050
diff-CA125 > 0 1.190 (0.932, 1.520) 0.163
diff-CA724 > 0 1.186 (0.946, 1.486) 0.139
  1. Units: AFU(U/L); AFP (ng/ml); CEA (ng/ml); CA199(U/ml); CA125(U/ml); CA724(U/ml)